UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 12, 2007
GENOPTIX, INC.
(Exact name of registrant as specified in its charter)
Delaware |
| 001-33753 |
| 33-0840570 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (I.R.S. Employer Identification |
2110 Rutherford Road
Carlsbad, CA 92008
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (760) 268-6200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On December 12, 2007, Genoptix, Inc., a Delaware corporation (the “Company”), issued a press release announcing its financial results for the third quarter and nine months ended September 30, 2007. A copy of the press release and accompanying information is attached as Exhibit 99.1 to this current report. The information in this Item 2.02 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof, and regardless of any general incorporation language in any such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 |
| Press Release issued by Genoptix, Inc., dated December 12, 2007. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
GENOPTIX, INC.
Dated: December 12, 2007 | By: | /s/ CHRISTIAN V. KUHLEN |
|
|
| Christian V. Kuhlen, M.D., Esq. | |
|
| Vice President, General Counsel | |
3
EXHIBIT INDEX
Exhibit Number |
| Description |
99.1 |
| Press Release issued by Genoptix, Inc., dated December 12, 2007. |
4
